4
Changes in Ownership
PROCEPT BioRobotics Corp Filed Acc 0001628280-23-041166
EVP, CFO sold 15,085 shares at an average $40.01 ($603,613)
- EVP, CFO acquired 15,085 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waters Kevin EVP, CFO | 2023-12-06 | Option exercise 10b5-1 | +4,360 | $4.52 | $19,707 | 37,883 | D |
| Waters Kevin EVP, CFO | 2023-12-07 | Option exercise 10b5-1 | +3,837 | $4.52 | $17,343 | 41,720 | D |
| Waters Kevin EVP, CFO | 2023-12-08 | Option exercise 10b5-1 | +6,888 | $4.52 | $31,134 | 48,608 | D |
| Waters Kevin EVP, CFO | 2023-12-06 | Sale 10b5-1 | −4,360 | $40.02 | $174,493 | 44,248 | D |
| Waters Kevin EVP, CFO | 2023-12-07 | Sale 10b5-1 | −3,837 | $40.00 | $153,480 | 40,411 | D |
| Waters Kevin EVP, CFO | 2023-12-08 | Sale 10b5-1 | −6,888 | $40.02 | $275,640 | 33,523 | D |
| Derivatives | |||||||
| Waters Kevin EVP, CFO | 2023-12-06 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,360 | 203,357 | D | ||
| Waters Kevin EVP, CFO | 2023-12-07 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,837 | 199,520 | D | ||
| Waters Kevin EVP, CFO | 2023-12-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,888 | 192,632 | D | ||
| Open-market sales · 15,085 sh · avg $40.01 · $603,613 | |||||||
Loading xslF345X05/wk-form4_1702076286.xml…